CAMBRIDGE, Mass. (AP) _ AVEO Pharmaceuticals Inc. (AVEO) on Tuesday reported fourth-quarter net income of $3.5 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the Cambridge, Massachusetts-based company said it had profit of 8 cents.
The cancer drug company posted revenue of $82,000 in the period.
For the year, the company reported that its loss widened to $65 million, or 61 cents per share. Revenue was reported as $7.6 million.
The company's shares closed at $3.06. A year ago, they were trading at 90 cents.